A Single Center, Single Arm, Open-label Study to Evaluate the Efficacy and Safety of Tacrolimus Modified Release, ADVAGRAF® After Treatment With a Tacrolimus in New Liver Transplant Recipients
Latest Information Update: 26 Feb 2021
At a glance
- Drugs Tacrolimus (Primary)
- Indications Liver transplant rejection
- Focus Adverse reactions
- Acronyms Assign
- 26 Feb 2021 New trial record